Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV
Emma Touizer, Aljawharah Alrubayyi, Chloe Rees-Spear, Natasha Fisher-Pearson, Sarah Griffith, Luke Muir, Pierre Pellegrino, Laura Waters, Fiona Burns, Sabine Kinloch, Sarah Rowland‐Jones, Ravindra K. Gupta, Richard Gilson, Dimitra Peppa, Laura E. McCoy
Topics & Concepts
MedicineImmunogenicitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ScopusAntibodyCoronavirus disease 2019 (COVID-19)Antibody responseVirologyClinical trialMEDLINEImmunologyInternal medicineBiologyBiochemistryDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesViral Infections and Immunology Research